Savara Obtains Global Rights to Develop and Commercialize Apulmiq

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. SPY
3. META
4. VRTX
5. LGND
6. ONON
7. USO
8. PSKY
9. ARAI
10. MA

Go back to Savara Obtains Global Rights to Develop and Commercialize Apulmiq
(NASDAQ: SVRA) Delayed: 5.47 +0.02 (0.37%)
Previous Close $5.45    52 Week High $ 
Open $5.52    52 Week Low $ 
Day High $5.53    P/E N/A 
Day Low $5.39    EPS $ 
Volume 310,912